SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028396
Filing Date
2016-11-09
Accepted
2016-11-08 18:20:42
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20160930.htm 10-Q 1394925
2 EX-4.3 tcon-ex43_150.htm EX-4.3 202829
3 EX-10.1 tcon-ex101_276.htm EX-10.1 1189381
4 EX-10.2 tcon-ex102_149.htm EX-10.2 301703
5 EX-31.1 tcon-ex311_6.htm EX-31.1 8143
6 EX-31.2 tcon-ex312_9.htm EX-31.2 8234
7 EX-32.1 tcon-ex321_8.htm EX-32.1 4898
8 EX-32.2 tcon-ex322_11.htm EX-32.2 4894
9 GRAPHIC g20161108223611341547.jpg GRAPHIC 40439
  Complete submission text file 0001564590-16-028396.txt   5958151

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT tcon-20160930.xml EX-101.INS 769049
11 XBRL TAXONOMY EXTENSION SCHEMA tcon-20160930.xsd EX-101.SCH 31909
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20160930_cal.xml EX-101.CAL 36099
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20160930_def.xml EX-101.DEF 101490
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20160930_lab.xml EX-101.LAB 256567
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20160930_pre.xml EX-101.PRE 180564
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 161982354
SIC: 2836 Biological Products, (No Diagnostic Substances)